David S. Geller

11.0k citations

130 papers · 7.2k indexed · 4 hit papers · h-index 38

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Hormonal Regulation and Hypertension
Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation

Papers in

Pulmonary and Respiratory Medicine 56
- Sarcoma Diagnosis and Treatment 44
Rheumatology 25
- Bone Tumor Diagnosis and Treatments 21
- Musculoskeletal synovial abnormalities and treatments 7

Co-authors: Richard Görlick Richard P. Lifton Ali G. Gharavi Jonathan Gill Valerae O. Lewis Douglas J. Harrison Junhui Zhang Dean G. Lorich
Journals: Cancer Research (7 papers)Journal of Bone and Joint Surgery (6 papers)Journal of the American Society of Nephrology (4 papers)Skeletal Radiology (4 papers)Cancer (4 papers)
Partner nations: United States China Canada

In The Last Decade

David S. Geller

123 papers receiving 7.1k citations

Hit Papers

align trajectories log scale

Current and future therapeutic approaches for osteosarcoma 2017 · 539 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Expert Review of Anticancer Therapy
2011 Science
2010 PubMed
2001 Cell

Peers

Countries citing papers authored by David S. Geller

Since Specialization

Citations

This map shows the geographic impact of David S. Geller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Geller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Geller more than expected).

Fields of papers citing papers by David S. Geller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Geller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Geller. The network helps show where David S. Geller may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David S. Geller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David S. Geller Line = papers co-authored together David S. Geller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A pan-cancer analysis revealed SKP2 as an inhibitor of the tumor immune microenvironment and a promising therapeutic target for immunotherapy Precision Clinical Medicine ·A. MISHRA, Yaxin Zhang, Xue Yu, Wei Du, Linxi Chen, Zhiqing Zhao, Haijie Liang, Xingyu Liu, Alex Miller, David S. Geller, Rui Yang, Bang H. Hoang, Pamela Butler Beeman, Jichuan Wang	2025	0
2	Artificial intelligence assisted preoperative planning and 3D-printing guiding frame for percutaneous screw reconstruction in periacetabular metastatic cancer patients Frontiers in Bioengineering and Biotechnology ·Jichuan Wang, Zhi‐Qing Zhao, Haijie Liang, de Campos Filho C, Xingyu Liu, Jing Zhang, Jamal Falahi, Wei Guo, Taiqiang Yan, Bang H. Hoang, David S. Geller, Xiaodong Tang, Rui Yang	2024	1
3	Area Socioeconomic Status is Associated with Refusal of Recommended Surgery in Patients with Metastatic Bone and Joint Disease Annals of Surgical Oncology ·I. O. Dyshlevyi, Rizka Indrawati, S. A. LUCENA FILHO, Didierdaneau, 贾福新, Hyun Song, Rafael De la Garza Ramos, Ananth Eleswarapu, Rui Yang, David S. Geller, Bang H. Hoang, Reza Yassari, Mitchell S. Fourman	2024	1
4	Novel candidate metastasis‐associated genes for synovial sarcoma Journal of Cellular and Molecular Medicine ·Zhiqing Zhao, Jianfang Niu, Jichuan Wang, de Campos Filho C, Haijie Liang, Natacha Sousa, С. С. Котов, Wei Wang, Rui Yang, David S. Geller, Tsukasa Wakao, Morseli Polizello, Bang H. Hoang, Xiaodong Tang, Taiqiang Yan	2024	2
5	SKP2 Knockout in Rb1/p53–Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis Molecular Cancer Therapeutics ·С. С. Котов, Jichuan Wang, de Campos Filho C, فراس عبدالقادر الکداوی, Ronaldo Souza Ferreira Silva, Jamal Falahi, Christoph Höcker, Edward L. Schwartz, R. A. Vila, Maja H. Oktay, Rui Yang, David S. Geller, Bang H. Hoang, Deyou Zheng	2023	12
6	A Novel Tripod Percutaneous Reconstruction Technique in Periacetabular Lesions Caused by Metastatic Cancer Journal of Bone and Joint Surgery ·Rui Yang, Ms. Dhara Patel, Dennis J. Murphy, Jichuan Wang, Vanessa Charubhumi, Jana Fox, Milan Sen, Bang H. Hoang, David S. Geller	2020	31
7	Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors Scientific Reports ·A.N. Bacherikov, Kevin J. Allen, 李振斌, Mackenzie E. Malo, Wojciech Dawicki, Muath Helal, Dale L. Godson, Ryan Dickinson, Angélica Flores-Flores, Rui Yang, Bang H. Hoang, Richard Görlick, David S. Geller, Ekaterina Dadachova	2019	24
8	Neoadjuvant radiation therapy for the management of myoepithelial carcinoma of the upper extremity International Journal of Cancer ·Rafi Kabarriti, Thomas J. Quinn, A. A. Polyatinskaya, Keyur Mehta, Shirley S. Scotti, David S. Geller, Shalom Kalnicki, Jana Fox	2017	10
9	Does the obesity paradox apply to early postoperative complications after hip surgery? A retrospective chart review Journal of Clinical Anesthesia ·Naum Shaparin, Mirzapour Soleyman, Singh Nair, Shade, David S. Geller, Ellise Delphin	2016	31
10	HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival Scientific Reports ·Pratistha Koirala, Michael Roth, Jonathan Gill, Jordan M. Chinai, A. A. Polyatinskaya, Sajida Piperdi, David S. Geller, Bang H. Hoang, Н.С. Блохина, A. Tamashiro, Xingxing Zang, Richard Görlick	2016	73
11	Thromboembolism After Intramedullary Nailing for Metastatic Bone Lesions Journal of Bone and Joint Surgery ·Pablo Ramon-Soria, 鹿英杰, 石﨑トモイ, David S. Geller, Alan Lee, John E. Ready, Geno J. Merli, Mitchell Maltenfort, John A. Abraham	2015	25
12	New Developments in the Genetics of Hypertension: What Should Clinicians Know? Current Cardiology Reports ·David S. Geller	2015	0
13	Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2 Clinical Cancer Research ·David S. Geller, 茂樹野原, Wendong Zhang, Jonathan Gill, Michael Roth, Mimi Kim, Xianhong Xie, Irma Catherin Bernal, Howard D. Dorfman, سمير بن عمور, Amy Park, Sajida Piperdi, Richard Görlick	2014	12
14	Progression of polycystic kidney disease in a kidney transplant Kidney International ·Alfred A. Vichot, David S. Geller, Mark A. Perazella	2013	3
15	Telescopic Mating Technique for Bulk Allograft Reconstruction Orthopedics ·Irma Catherin Bernal, David S. Geller	2012	2
16	K ⁺ Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension Science ·Murim Choi, Ute I. Scholl, Peng Yue, Peyman Björklund, Bixiao Zhao, Carol Nelson‐Williams, Weizhen Ji, Yoonsang Cho, Aniruddh P. Patel, Clara J. Men, Elias Lolis, Max Wisgerhof, David S. Geller, Shrikant Mane, Per Hellman, Gunnar Westin, Göran Åkerström, Wen‐Hui Wang, Tobias Carling, Richard P. Lifton Hit paper breakdown →	2011	679
17	Cell surface receptor expression patterns in osteosarcoma Cancer ·Stany Mariya Joji, 罗来盛, Mimi Kim, Juan Lin, Sajida Piperdi, Richard Görlick, David S. Geller	2011	84
18	A Novel Form of Human Mendelian Hypertension Featuring Nonglucocorticoid-Remediable Aldosteronism The Journal of Clinical Endocrinology & Metabolism ·David S. Geller, Junhui Zhang, Max Wisgerhof, Cedric Shackleton, Michael Kashgarian, Richard P. Lifton	2008	190
19	Helix 3–helix 5 interactions in steroid hormone receptor function The Journal of Steroid Biochemistry and Molecular Biology ·Junhui Zhang, David S. Geller	2008	7
20	A mineralocorticoid receptor mutation causing human hypertension Current Opinion in Nephrology & Hypertension ·David S. Geller	2001	11

About David S. Geller

David S. Geller is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Endocrinology, Diabetes and Metabolism, Surgery and Oncology, having authored 130 papers that have together received 7.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (44 papers), Bone Tumor Diagnosis and Treatments (21 papers), Hormonal Regulation and Hypertension (19 papers), Ion Transport and Channel Regulation (17 papers), Management of metastatic bone disease (14 papers), Total Knee Arthroplasty Outcomes (7 papers), Musculoskeletal synovial abnormalities and treatments (7 papers) and Pelvic and Acetabular Injuries (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.9k citations), Cancer Research (887 citations), Pulmonary and Respiratory Medicine (1.7k citations), Molecular Biology (3.1k citations) and Surgery (1.8k citations). David S. Geller has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Richard Görlick, Richard P. Lifton, Ali G. Gharavi, Jonathan Gill, Valerae O. Lewis, Douglas J. Harrison, Junhui Zhang, Dean G. Lorich, Julie E. Goodwin and Sajida Piperdi. Their work appears in journals such as Cancer Research, Journal of Bone and Joint Surgery, Journal of the American Society of Nephrology, Skeletal Radiology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact